2731 - 2740 of 9134 Results
Title
Year
-
OPENTitle: Putting participants and study partners FIRST when clinical trials end earlyJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 18Issue #: 12Start Page: 2736End Page: 2746Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/alz.12732Best OA location URL: https://doi.org/10.1002/alz.12732Citation Count: 12
- Baseline-dependency: How genotype and signaled delays influence amphetamine's effects on delay discounting2020RESTRICTEDTitle: Baseline-dependency: How genotype and signaled delays influence amphetamine's effects on delay discountingJournal Name: Pharmacology Biochemistry and BehaviorPublisher: Elsevier BVVol: 199Issue #:Start Page: 173070End Page: 173070Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.pbb.2020.173070Citation Count: 10
-
OPENTitle: Patient-Centered Identification of Meaningful Regulatory Endpoints for Medical Devices to Treat Parkinson’s DiseaseJournal Name: MDM Policy & PracticePublisher: SAGE PublicationsVol: 6Issue #: 1Start Page: 23814683211021380End Page: 23814683211021380Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1177/23814683211021380Best OA location URL: https://journals.sagepub.com/doi/pdf/10.1177/23814683211021380Citation Count: 14
- Addition of Filgrastim (Neupogen) for Clozapine Rechallenge in the Case of Parkinson Disease Patient2017RESTRICTEDTitle: Addition of Filgrastim (Neupogen) for Clozapine Rechallenge in the Case of Parkinson Disease PatientJournal Name: Clinical NeuropharmacologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 40Issue #: 5Start Page: 233End Page: 234Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1097/wnf.0000000000000230Citation Count: 7
-
OPENTitle: Use of Bayesian decision analysis to maximize value in patient-centered randomized clinical trials in Parkinson’s diseaseJournal Name: Journal of Biopharmaceutical StatisticsPublisher: Informa UK LimitedVol: 35Issue #: 5Start Page: 981End Page: 1000Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1080/10543406.2023.2170400Best OA location URL: https://doi.org/10.1080/10543406.2023.2170400Citation Count: 8
- Including People with Parkinson’s Disease in Clinical Study Design and Execution: A Call to Action2022OPENTitle: Including People with Parkinson’s Disease in Clinical Study Design and Execution: A Call to ActionJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 12Issue #: 4Start Page: 1359End Page: 1363Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-223190Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd223190?id=journal-of-parkinsons-disease%2Fjpd223190Citation Count: 15
- GBA‐associated parkinsonism and dementia: beyond α‐synucleinopathies?2015RESTRICTEDTitle: GBA‐associated parkinsonism and dementia: beyond α‐synucleinopathies?Journal Name: European Journal of NeurologyPublisher: WileyVol: 23Issue #: 3Start Page: 520End Page: 526Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/ene.12894Citation Count: 12
-
OPENTitle: A Single Amino Acid Determines the Selectivity and Efficacy of Selective Negative Allosteric Modulators of CaV1.3 L-Type Calcium ChannelsJournal Name: ACS Chemical BiologyPublisher: American Chemical Society (ACS)Vol: 15Issue #: 9Start Page: 2539End Page: 2550Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acschembio.0c00577Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7502546Citation Count: 17
- Novel decision algorithm to discriminate parkinsonism with combined blood and imaging biomarkers2020OPENTitle: Novel decision algorithm to discriminate parkinsonism with combined blood and imaging biomarkersJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 77Issue #:Start Page: 57End Page: 63Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.05.033Best OA location URL: http://www.prd-journal.com/article/S1353802020301504/pdfCitation Count: 28
-
OPENTitle: Prodromal Lewy Body Disorder Features in REM Sleep Behavior Disorder With Biomarker‐Defined SynucleinopathyJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/acn3.70399Best OA location URL: https://doi.org/10.1002/acn3.70399Citation Count: 1